Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $10.07 billion. The enterprise value is $11.83 billion.
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 188.64 million shares outstanding. The number of shares has increased by 2.33% in one year.
| Current Share Class | 188.64M |
| Shares Outstanding | 188.64M |
| Shares Change (YoY) | +2.33% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 98.31% |
| Float | 186.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 99.00 |
| PS Ratio | 3.50 |
| Forward PS | 3.11 |
| PB Ratio | 4.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 51.89 |
| P/OCF Ratio | 31.12 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 264.08, with an EV/FCF ratio of 60.92.
| EV / Earnings | n/a |
| EV / Sales | 4.18 |
| EV / EBITDA | 264.08 |
| EV / EBIT | n/a |
| EV / FCF | 60.92 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 1.06.
| Current Ratio | 2.73 |
| Quick Ratio | 2.12 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 29.63 |
| Debt / FCF | 13.08 |
| Interest Coverage | -5.86 |
Financial Efficiency
Return on equity (ROE) is -36.89% and return on invested capital (ROIC) is -2.00%.
| Return on Equity (ROE) | -36.89% |
| Return on Assets (ROA) | -1.76% |
| Return on Invested Capital (ROIC) | -2.00% |
| Return on Capital Employed (ROCE) | -3.27% |
| Revenue Per Employee | $404,018 |
| Profits Per Employee | -$145,692 |
| Employee Count | 7,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.61 |
Taxes
| Income Tax | -8.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.21% in the last 52 weeks. The beta is 0.92, so Exact Sciences's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -0.21% |
| 50-Day Moving Average | 45.97 |
| 200-Day Moving Average | 55.94 |
| Relative Strength Index (RSI) | 66.53 |
| Average Volume (20 Days) | 2,716,561 |
Short Selling Information
The latest short interest is 10.12 million, so 5.36% of the outstanding shares have been sold short.
| Short Interest | 10.12M |
| Short Previous Month | 10.73M |
| Short % of Shares Out | 5.36% |
| Short % of Float | 5.41% |
| Short Ratio (days to cover) | 4.28 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.83 billion and -$1.02 billion in losses. Loss per share was -$5.51.
| Revenue | 2.83B |
| Gross Profit | 1.97B |
| Operating Income | -170.20M |
| Pretax Income | -172.10M |
| Net Income | -1.02B |
| EBITDA | 44.78M |
| EBIT | -170.20M |
| Loss Per Share | -$5.51 |
Full Income StatementBalance Sheet
The company has $786.18 million in cash and $2.54 billion in debt, giving a net cash position of -$1.75 billion or -$9.29 per share.
| Cash & Cash Equivalents | 786.18M |
| Total Debt | 2.54B |
| Net Cash | -1.75B |
| Net Cash Per Share | -$9.29 |
| Equity (Book Value) | 2.40B |
| Book Value Per Share | 12.71 |
| Working Capital | 867.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $323.66 million and capital expenditures -$129.51 million, giving a free cash flow of $194.14 million.
| Operating Cash Flow | 323.66M |
| Capital Expenditures | -129.51M |
| Free Cash Flow | 194.14M |
| FCF Per Share | $1.03 |
Full Cash Flow StatementMargins
Gross margin is 69.76%, with operating and profit margins of -6.02% and -36.06%.
| Gross Margin | 69.76% |
| Operating Margin | -6.02% |
| Pretax Margin | -36.37% |
| Profit Margin | -36.06% |
| EBITDA Margin | 1.58% |
| EBIT Margin | -6.02% |
| FCF Margin | 6.86% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.33% |
| Shareholder Yield | -2.33% |
| Earnings Yield | -10.12% |
| FCF Yield | 1.93% |
Dividend DetailsAnalyst Forecast
The average price target for Exact Sciences is $70.68, which is 32.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $70.68 |
| Price Target Difference | 32.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 10.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 5 |